propranolol has been researched along with Fetal Hypoxia in 12 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Fetal Hypoxia: Deficient oxygenation of FETAL BLOOD.
Excerpt | Relevance | Reference |
---|---|---|
"Propranolol, 1." | 1.27 | The influence of beta-adrenergic activity on fetal heart rate and the umbilical circulation during hypoxia in fetal sheep. ( Parer, JT, 1983) |
"Propranolol was found to completely abolish the FECG changes induced by isoprenaline, as well as by mild hypoxia." | 1.26 | ECG-changes in the fetal lamb during asphyxia in relation to beta-adrenoceptor stimulation and blockade. ( Hökegård, KH; Karlsson, K; Kjellmer, I; Rosén, KG, 1979) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (83.33) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Lear, CA | 1 |
Beacom, MJ | 1 |
Kasai, M | 1 |
Westgate, JA | 1 |
Galinsky, R | 1 |
Magawa, S | 1 |
Miyagi, E | 1 |
Ikeda, T | 1 |
Bennet, L | 1 |
Gunn, AJ | 1 |
Parer, JT | 2 |
Jones, CT | 3 |
Ritchie, JW | 2 |
Speiser, Z | 1 |
Shved, A | 1 |
Gitter, S | 1 |
Court, DJ | 1 |
Block, BS | 1 |
Llanos, AJ | 1 |
Walker, D | 1 |
Fignon, A | 1 |
Arbeille, P | 1 |
Berson, M | 1 |
Bodart, S | 1 |
Locatelli, A | 1 |
Hökegård, KH | 1 |
Karlsson, K | 1 |
Kjellmer, I | 1 |
Rosén, KG | 1 |
Robinson, JS | 1 |
Thorburn, GD | 1 |
Walker, AM | 2 |
Cannata, JP | 1 |
Dowling, MH | 2 |
Ritchie, BC | 2 |
Maloney, JE | 2 |
Cannata, J | 1 |
James, LS | 1 |
Yeh, MN | 1 |
Morishima, HO | 1 |
Daniel, SS | 1 |
Caritis, SN | 1 |
Niemann, WH | 1 |
Indyk, L | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)[NCT01131260] | 11,108 participants (Actual) | Interventional | 2010-11-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
The Apgar score is a simple method of quickly assessing the health and vital signs of a newborn baby created by and named after Dr. Virginia Apgar. Apgar testing assesses Appearance, Pulse, Grimace and Activity in a newborn and is typically done at one and five minutes after a baby is born, and it may be repeated at 10, 15, and 20 minutes if the score is low. The five criteria are each scored as 0, 1, or 2 (two being the best), and the total score is calculated by then adding the five values obtained. Agar scores of 0-3 are critically low, 4-6 are below normal, and indicate that the baby likely requires medical intervention, scores of 7+ are considered normal. The lower the Apgar score, the more alert the medical team should be to the possibility of the baby requiring intervention. Some components of the Apgar score are subjective, and there are cases in which a baby requires urgent medical treatment despite having a high Apgar score. (NCT01131260)
Timeframe: 5 minutes after Delivery
Intervention | score on a scale (Median) |
---|---|
Open Group | 9 |
Masked Group | 9 |
Duration of labor in hours after randomization through delivery (NCT01131260)
Timeframe: Onset of Labor through delivery
Intervention | Hours (Median) |
---|---|
Open Group | 3.8 |
Masked Group | 3.9 |
Days of stay in the hospital (NCT01131260)
Timeframe: From admission to labor and delivery through hospital discharge
Intervention | Days (Median) |
---|---|
Open Group | 2 |
Masked Group | 2 |
Intermediate care nursery or neonatal intensive care (anything more than well-baby nursery) (NCT01131260)
Timeframe: Delivery and 1 month of age
Intervention | Participants (Count of Participants) |
---|---|
Open Group | 498 |
Masked Group | 470 |
Neonatal encephalopathy experienced between delivery and discharge (NCT01131260)
Timeframe: Delivery through hospital discharge
Intervention | Participants (Count of Participants) |
---|---|
Open Group | 4 |
Masked Group | 5 |
Number of infants who experienced Neonatal Seizure (NCT01131260)
Timeframe: Birth through hospital discharge
Intervention | Participants (Count of Participants) |
---|---|
Open Group | 3 |
Masked Group | 4 |
Major congenital malformation (NCT01131260)
Timeframe: Delivery
Intervention | Participants (Count of Participants) |
---|---|
Open Group | 38 |
Masked Group | 23 |
The Apgar score is a simple method of quickly assessing the health and vital signs of a newborn baby created by and named after Dr. Virginia Apgar. Apgar testing assesses Appearance, Pulse, Grimace and Activity in a newborn and is typically done at one and five minutes after a baby is born, and it may be repeated at 10, 15, and 20 minutes if the score is low. The five criteria are each scored as 0, 1, or 2 (two being the best), and the total score is calculated by then adding the five values obtained. Agar scores of 0-3 are critically low, 4-6 are below normal, and indicate that the baby likely requires medical intervention, scores of 7+ are considered normal. The lower the Apgar score, the more alert the medical team should be to the possibility of the baby requiring intervention. Some components of the Apgar score are subjective, and there are cases in which a baby requires urgent medical treatment despite having a high Apgar score. The lowest score is 0, the highest score is 10. (NCT01131260)
Timeframe: 5 minutes after delivery
Intervention | Participants (Count of Participants) |
---|---|
Open Group | 17 |
Masked Group | 6 |
Meconium aspiration syndrome (NCT01131260)
Timeframe: Delivery through discharge
Intervention | Participants (Count of Participants) |
---|---|
Open Group | 20 |
Masked Group | 20 |
Umbilical-artery blood pH < = 7.05 and base deficit in extracellular fluid > = 12 mmol/liter (NCT01131260)
Timeframe: Delivery
Intervention | Participants (Count of Participants) |
---|---|
Open Group | 3 |
Masked Group | 8 |
Death of the fetus during the intrapartum period. (NCT01131260)
Timeframe: During labor and through delivery of the baby
Intervention | Participants (Count of Participants) |
---|---|
Open Group | 0 |
Masked Group | 0 |
Death of the newborn between delivery and1 month of age (NCT01131260)
Timeframe: Delivery through1 month of age
Intervention | Participants (Count of Participants) |
---|---|
Open Group | 3 |
Masked Group | 1 |
Neonatal intubation for ventilation in the delivery room (NCT01131260)
Timeframe: Delivery
Intervention | Participants (Count of Participants) |
---|---|
Open Group | 42 |
Masked Group | 27 |
Presence of shoulder dystocia during delivery (NCT01131260)
Timeframe: Delivery
Intervention | Participants (Count of Participants) |
---|---|
Open Group | 141 |
Masked Group | 158 |
Postpartum endometritis (NCT01131260)
Timeframe: Delivery through hospital discharge
Intervention | Participants (Count of Participants) |
---|---|
Open Group | 71 |
Masked Group | 88 |
Blood transfusion from delivery and through hospital stay until discharge (NCT01131260)
Timeframe: Delivery through hospital discharge
Intervention | Participants (Count of Participants) |
---|---|
Open Group | 80 |
Masked Group | 74 |
Chorioamnionitis (NCT01131260)
Timeframe: Any time from Randomization through Delivery
Intervention | Participants (Count of Participants) |
---|---|
Open Group | 286 |
Masked Group | 269 |
Composite primary outcome of intrapartum fetal death, neonatal death, Apgar score <=3 at 5 minutes, neonatal seizure, umbilical artery blood pH <= 7.05 with base deficit >=12 mmol/L in extra-cellular fluid, intubation for ventilation at delivery, neonatal encelphalopathy (NCT01131260)
Timeframe: From Delivery through 1 month of age
Intervention | Participants (Count of Participants) |
---|---|
Open Group | 52 |
Masked Group | 40 |
Indication for delivery by forceps or vacuum (NCT01131260)
Timeframe: During labor through delivery
Intervention | Participants (Count of Participants) | ||
---|---|---|---|
Fetal indication | Dystocia | Other | |
Masked Group | 218 | 101 | 8 |
Open Group | 225 | 95 | 9 |
1 review available for propranolol and Fetal Hypoxia
Article | Year |
---|---|
The effects of hypoxaemia in fetal sheep.
Topics: Adrenocorticotropic Hormone; Animals; Blood Pressure; Chronic Disease; Disease Models, Animal; Epine | 1977 |
11 other studies available for propranolol and Fetal Hypoxia
Article | Year |
---|---|
Circulating catecholamines partially regulate T-wave morphology but not heart rate variability during repeated umbilical cord occlusions in fetal sheep.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Animals; Catecholamines; Electrocardio | 2020 |
The influence of beta-adrenergic activity on fetal heart rate and the umbilical circulation during hypoxia in fetal sheep.
Topics: Adrenergic beta-Antagonists; Animals; Atropine; Blood Circulation; Female; Fetal Heart; Fetal Hypoxi | 1983 |
The effects of adrenergic blockade on fetal response to hypoxia.
Topics: Adrenocorticotropic Hormone; Animals; Blood Pressure; Epinephrine; Female; Fetal Blood; Fetal Hypoxi | 1983 |
Effect of propranolol treatment in pregnant rats on motor activity and avoidance learning of the offspring.
Topics: Aging; Animals; Avoidance Learning; Behavior, Animal; Female; Fetal Hypoxia; Male; Motor Activity; P | 1983 |
Effects of beta-adrenergic blockade on blood flow distribution during hypoxaemia in fetal sheep.
Topics: Adrenal Glands; Animals; Cerebrovascular Circulation; Coronary Circulation; Female; Fetal Hypoxia; H | 1984 |
The effects of hypoxia on glucose turnover in the fetal sheep.
Topics: Animals; Female; Fetal Blood; Fetal Hypoxia; Fetus; Glucose; Oxygen Consumption; Phentolamine; Place | 1983 |
[Refinement of a new Doppler sensor for studying fetal hemodynamic disorders (animal model)].
Topics: Animals; Cerebrovascular Circulation; Disease Models, Animal; Female; Fetal Hypoxia; Fetal Monitorin | 1993 |
ECG-changes in the fetal lamb during asphyxia in relation to beta-adrenoceptor stimulation and blockade.
Topics: Animals; Blood Glucose; Blood Pressure; Cardiac Output; Electrocardiography; Female; Fetal Hypoxia; | 1979 |
Age-dependent pattern of autonomic heart rate control during hypoxia in fetal and newborn lambs.
Topics: Age Factors; Animals; Animals, Newborn; Asphyxia Neonatorum; Atropine; Autonomic Nervous System; Blo | 1979 |
Different patterns of autonomic heart rate control during hypoxia in fetal and newborn lambs.
Topics: Animals; Animals, Newborn; Atropine; Female; Fetal Heart; Fetal Hypoxia; Heart Rate; Hypoxia; Pregna | 1977 |
Umbilical vein occlusion and transient acceleration of the fetal heart rate. Experimental observations in subhuman primates.
Topics: Animals; Blood Circulation; Blood Pressure; Constriction; Female; Fetal Heart; Fetal Hypoxia; Haplor | 1976 |